EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Degradation‐Based Protein Profiling: A Case Study of Celastrol

Zhihao Ni iD, Yi Shi, Qianlong Liu, Liguo Wang, Xiuyun Sun, Yu Rao iD

Advanced Science · 2024-07 · 11 (25)

DOI: 10.1002/advs.202308186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.04.2024. Verfasst von Zhihao Ni und 5 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Protein Sciences, School of Pharmaceutical Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, …. Hauptthemen laut MEDLINE: Pentacyclic Triterpenes, Proteomics, Triterpenes. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural products, while valuable for drug discovery, encounter limitations like uncertainty in targets and toxicity. As an important active ingredient in traditional Chinese medicine, celastrol exhibits a wide range of biological activities, yet its mechanism remains unclear. In this study, they introduced an innovative “Degradation‐based protein profiling (DBPP)” strategy, which combined PROteolysis TArgeting Chimeras (PROTAC) technology with quantitative proteomics and Immunoprecipitation‐Mass Spectrometry (IP‐MS) techniques, to identify multiple targets of natural products using a toolbox of degraders. Taking celastrol as an example, they successfully identified its known targets, including inhibitor of nuclear factor kappa B kinase subunit beta (IKKβ), phosphatidylinositol‐4,5‐bisphosphate 3‐kinase catalytic subunit alpha (PI3Kα), and cellular inhibitor of PP2A (CIP2A), as well as potential new targets such as checkpoint kinase 1 (CHK1), O‐GlcNAcase (OGA), and DNA excision repair protein ERCC‐6‐like (ERCC6L). Furthermore, the first glycosidase degrader is developed in this work. Finally, by employing a mixed PROTAC toolbox in quantitative proteomics, they also achieved multi‐target identification of celastrol, significantly reducing costs while improving efficiency. Taken together, they believe that the DBPP strategy can complement existing target identification strategies, thereby facilitating the rapid advancement of the pharmaceutical field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pentacyclic TriterpenesProteomicsTriterpenesHumansProteolysisMass SpectrometryImmunoprecipitation

Stichwörter der Autor:innen

DBPPPROTACcelastroltoolbox

Substanzen

celastrolPentacyclic TriterpenesTriterpenes

Autor:innen und Institutionen

  • MOE Key Laboratory of Protein Sciences, School of Pharmaceutical Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Tsinghua University, Beijing, 100084, China.
  • Changping Laboratory, Beijing, 102206, China.

ORCID-Profile: Zhihao Ni, Yu Rao

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Ni, Z., Shi, Y., Liu, Q., Wang, L., Sun, X., & Rao, Y. (2024). Degradation‐Based Protein Profiling: A Case Study of Celastrol. Advanced Science, 11(25). https://doi.org/10.1002/advs.202308186

Vancouver

Ni Z, Shi Y, Liu Q, Wang L, Sun X, Rao Y. Degradation‐Based Protein Profiling: A Case Study of Celastrol. Advanced Science. 2024;11(25). doi:10.1002/advs.202308186

BibTeX
@article{Ni2024,
  author = {Ni, Zhihao and Shi, Yi and Liu, Qianlong and Wang, Liguo and Sun, Xiuyun and Rao, Yu},
  title = {Degradation‐Based Protein Profiling: A Case Study of Celastrol},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {25},
  doi = {10.1002/advs.202308186}
}
Kostenlos starten →